MAPK3 and cholangiocarcinoma: In particular, CBAs-induced activation of S1PR2-mediated cholestasis liver injury in mice and invasive growth of human CCA cells by ERK1/2 and AKT Signaling pathway (Liu et al., 2015; Wang et al., 2017).